Dr. Chantelle Thomas

speaker

1,116 appearances 2 recordings 1 series first heard Jul 2026 last heard 30 Jul

Dr. Chantelle Thomas’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Jul 2026 with 2.

Appearances

newest first · ▶ plays the moment

RECOVERable: Mental Health and Addiction Experts Answer Your Questions · Psilocybin & Ibogaine: Can Psychedelics Cure Addiction? · 30 Jul 2026 podcast

And when it doesn't show up in that exact way, people can get very disappointed or frustrated or feel like they are doing it wrong or somehow they weren't chosen to respond to it.

So a lot of the support that's being mediated is actually in navigating the non-linearity.

So things aren't A to B to C to D and the unpredictability of these compounds.

And it's actually a lot of the work is going into how do you stay open to something that may be different than you think it's going to be?

How do you engage with the content as it's emerging?

And how will you choose to make sense of it afterwards?

So that's a little bit of a different nuance that I want to underscore.

Okay.

And that's not to say that that that anytime you see psychedelic fill in the blank, whichever compound assisted therapy, that should be a strong component of what's happening is supporting someone in addressing these drug effects and what are the impacts of it.

But it's important to note that the therapy is not being attached to these drugs as they're going towards the FDA finish line.

Which is different than saying... Well, now MDMA-assisted therapy was going to the finish line attached to a therapy, even though the FDA can't regulate therapy.

Then it's this very interesting conundrum of a drug being approved, and then it's the sponsors that get to decide what gets attached to it to some extent.

But it's just the drug that's being approved under a certain set of circumstances and certain sort of safety profile, and they will have risk mitigation strategies that they'll have to put in place.

But...

This is just real complex.

And I think it's important that listeners understand the different nuances in terms of the way these things are being talked about.

For example, if you went to Oregon to one of these wellness centers, it'd probably be very limited amount of preparation that's happening for that process and the way that you're supported.

And it is really about giving you an experience to have you with the drug itself in a somewhat monitored environment.

But

You're not going to get a lot of nuances there in terms of the therapeutic container because they're not technically doing therapy in those wellness centers.

Showing 161–180 of 1,116 · page 9 of 56